## AIG: American International Group, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($81.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Inglis buys American International Group shares worth $1,200 By Investing.com**
- Source: Investing.com UK | 20251231T220737 | Bullish | Relevance: 100%
- John C. Inglis, a director at American International Group (NYSE:AIG), recently purchased shares worth approximately $1,200, according to a Form 4 filing. This insider buying reflects management's confidence and comes as AIG trades near its 52-week high, supported by share buybacks and a solid "GOOD" financial health rating from InvestingPro. The company has also been involved in strategic mergers, partnerships, and leadership changes, alongside positive dividend growth.

**2. American International Group (AIG) director John C. Inglis purchases AIG stock**
- Source: Stock Titan | 20260101T030810 | Somewhat-Bullish | Relevance: 100%
- John C. Inglis, a director at American International Group, Inc. (AIG), reported an open-market purchase of 13.8791 shares of AIG common stock on December 30, 2025, at a price of $86.47 per share. Following this transaction, Inglis directly owns 2,680.844 shares of AIG. This transaction was disclosed in a Form 4 SEC filing.

**3. Ayrshire Capital Management LLC Has $5.45 Million Position in American International Group, Inc. $AIG**
- Source: MarketBeat | 20251231T084956 | Somewhat-Bullish | Relevance: 100%
- Ayrshire Capital Management LLC reduced its stake in American International Group (AIG) by 25.4% during Q3, now holding 69,417 shares valued at $5.45 million. The firmâ€™s AIG position constitutes about 2.5% of its portfolio. Analysts have a "Hold" consensus rating with a target price of $89.28, while AIG reported strong Q3 EPS, beating estimates.

**4. CCC: Piper Sandler projects strong insurtech growth driven by AI efficiencies and favorable claims environment**
- Source: MSN | 20251231T170852 | Bullish | Relevance: 87%
- Piper Sandler anticipates robust growth in the insurance technology (insurtech) sector, fueled by advancements in Artificial Intelligence (AI) that enhance operational efficiencies. The firm also points to a favorable claims environment as another key driver for this projected expansion.

**5. Amdocs founder Morris Kahn dies aged 95**
- Source: Globes - Israel Business News | 20260101T102000 | Neutral | Relevance: 70%
- Morris Kahn, the Israeli billionaire and co-founder of telecom billing company Amdocs, has died at the age of 95. Kahn was a pioneer in Israel's high-tech industry, establishing Amdocs and investing in numerous other businesses. He was known for his sharp business acumen and later became a major donor for the SpaceIL lunar project.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Piper Sandler | $95 | $88 | +8% |
| 2025-12-16 | TD Cowen | $90 | $86 | +5% |
| 2025-12-16 | Mizuho | $84 | $0 | 0% |
| 2025-12-05 | Barclays | $88 | $95 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Piper Sandler | main | Overweight |
| 2025-12-16 | TD Cowen | main | Hold |
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-05 | Barclays | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 5 ($1017.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+11.6%)
- Blackrock Inc.: 8.7% (-1.7%)
- Capital Research Glo: 5.3% (+79.6%)
- Wellington Managemen: 4.8% (+7.9%)
- State Street Corpora: 4.7% (-3.2%)

### Key Risks

1. Heavy insider selling: $1018M sold (5 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.85 indicates undervaluation relative to growth. Forward P/E 10.7x attractive for 13% earnings growth. Balance sheet: strong liquidity (9.6x). Analyst sentiment positive (2 raises, avg +6%). Insider selling cluster ($1018.0M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.7B |
| Beta | 0.63 |
| 52W Range | $69.24 - $88.07 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.85 |
| Forward P/E | 10.7 |
| Current P/E | 12.1 |
| YoY Growth | 13.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.45% (CS: 18) | Neutral |
| RSI_14 | 56.8 | Neutral |
| MACD Histogram | -0.15 | Bearish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 1.055x | Above |
| vs SMA200 | 1.038x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $84.27
- **Stop Loss:** $81.23 (3.6% risk)
- **Target:** $87.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 473
- **Position Value:** $39,859.71
- **Portfolio %:** 39.86%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-10 (Est: $1.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.71 | $2.20 | +28.5% |
| 2025Q2 | $1.60 | $1.81 | +13.2% |
| 2025Q1 | $0.99 | $1.17 | +17.6% |
| 2024Q4 | $1.23 | $1.30 | +6.0% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*